Robb Gary Charles

Robb Gary Charles is listed in filings as Chief Business Officer at Corcept Therapeutics Incorporated. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Corcept Therapeutics Incorporated (CORT). The current snapshot covers public activity from Jun 18, 2025 to Jun 3, 2026. Reported amounts are shown as $25.2K to $4.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.